A bottom-up design platform combining first-principles calculations and machine learning to develop novel Bi/Sb-based semiconductor photocatalysts that efficiently generate hydroxyl radicals under visible light for antimicrobial disinfection applications.
This solution offers a rational, computation-driven approach to designing semiconductor photocatalysts that generate hydroxyl radicals under visible light for disinfection. Current photocatalyst development has relied on empirical trial-and-error, yielding only modest improvements in antimicrobial activity over decades. By combining first-principles electronic structure calculations with machine learning, this platform accelerates the discovery of semiconductor materials with tailored optical and electronic properties optimized for hydroxyl radical generation, enabling effective visible-light-driven disinfection without reliance on UV light.
The approach is at an early-to-mid stage of development. Prior work has computationally identified and experimentally synthesized a Bi-based oxide perovskite (KBaTeBiO6), demonstrating feasibility of the design-to-synthesis workflow. Sadtler's group has established spectroscopic methods for quantifying hydroxyl radical generation and characterizing the role of crystal defects and surface structure in photocatalysts including bismuth vanadate and tungsten oxide. The initial 6-month milestone targets identification and validation of a novel semiconductor with visible-light absorption and photocatalytic activity rivaling TiO2. Broader antimicrobial efficacy testing represents the next stage of validation.
Washington University in St. Louis is a private research university with a large graduate and professional footprint and a major clinical enterprise. Its medical campus is integrated with a leading hospital system, enabling joint clinical research, secure data access, and large-scale trial recruitment. An adjacent innovation district and partner incubators provide flexible lab space, prototyping resources, and corporate co-location, while shared core facilities welcome external users under service agreements. Research is supported by NIH, NSF, DOE, and other competitive federal funding alongside industry sponsorship. A dedicated technology transfer office manages IP, licensing, startup formation, and streamlined sponsored research and clinical trial agreements.